The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Inflammatory mechanisms in Alzheimer's disease: implications for therapy
Abstract
OBJECTIVE: The purpose of this article is to review evidence that inflammatory and immune mechanisms are important in the pathophysiology of Alzheimer's disease and to suggest new treatment strategies. METHOD: The authors review the English-language literature of the last 10 years pertaining to the pathophysiology of Alzheimer's disease. RESULTS: There is ample evidence supporting the hypothesis that inflammatory and immune mechanisms are involved in tissue destruction in Alzheimer's disease. Acute phase proteins are elevated in the serum and are deposited in amyloid plaques, activated microglial cells that stain for inflammatory cytokines accumulate around senile plaques, and complement components including the membrane attack complex are present around dystrophic neurites and neurofibrillary tangles. CONCLUSIONS: Clinical trials of anti-inflammatory/immunosuppressive drugs are necessary to determine whether alteration of these inflammatory mechanisms can slow the progression of Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,410
Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging
Sapolsky, R., Krey, L., & McEwen, B. (1985) · The Journal of Neuroscience · doi:10.1523/jneurosci.05-05-01222.1985 · Cited by 1,129
Goodman and Gilman's The Pharmacological Basis of Therapeutics
Hastings, R. C., & Long, G. W. (1991) · JAMA · doi:10.1001/jama.1991.03460200114048 · Cited by 1,060
Clinical trial of indomethacin in Alzheimer's disease
Rogers, J., Kirby, L. C., Hempelman, S. R., Berry, D. L., McGeer, P. L., Kaszniak, A. W., Zalinski, J., Cofield, M., Mansukhani, L., Willson, P., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1609 · Cited by 999
Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease
Yankner, B. A., Dawes, L. R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M. L., & Neve, R. L. (1989) · Science · doi:10.1126/science.2474201 · Cited by 907
Abraham, C. R., Selkoe, D. J., & Potter, H. (1988) · Cell · doi:10.1016/0092-8674(88)90462-x · Cited by 900
Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytes
Castell, J. V., Gómez-Lechón, M. J., David, M., Andus, T., Geiger, T., Trullenque, R., Fabra, R., & Heinrich, P. C. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80476-4 · Cited by 893
Interleukin 1 of the central nervous system is produced by ameboid microglia.
Giulian, D., Baker, T. J., Shih, L. C., & Lachman, L. B. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.2.594 · Cited by 859
Complement activation by beta-amyloid in Alzheimer disease.
Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817
Rogers, J., Luber-Narod, J., Styren, S. D., & Civin, W. H. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80079-4 · Cited by 743
Processing of the Amyloid Protein Precursor to Potentially Amyloidogenic Derivatives
Golde, T. E., Estus, S., Younkin, L. H., Selkoe, D. J., & Younkin, S. G. (1992) · Science · doi:10.1126/science.1738847 · Cited by 737
Frei, K., Malipiero, U. V., Leist, T. P., Zinkernagel, R. M., Schwab, M. E., & Fontana, A. (1989) · European Journal of Immunology · doi:10.1002/eji.1830190418 · Cited by 692
A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Disease
Davis, K. L., Thal, L. J., Gamzu, E. R., Davis, C. S., Woolson, R. F., Gracon, S. I., Drachman, D. A., Schneider, L. S., Whitehouse, P. J., Hoover, T. M., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271801 · Cited by 626
Self-citationChung, I. Y., & Benveniste, E. N. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.8.2999 · Cited by 609
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-507_3 · Cited by 592
Elevated circulating tumor necrosis factor levels in Alzheimer's disease
Fillit, H., Ding, W., Buee, L., Kalman, J., Altstiel, L., Lawlor, B., & Wolf-Klein, G. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90490-k · Cited by 512
Hippocampal Aging and Adrenocorticoids: Quantitative Correlations
Landfield, P. W., Waymire, J. C., & Lynch, G. (1978) · Science · doi:10.1126/science.715460 · Cited by 489
Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices
Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Yolk, B., & Berger, M. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80737-n · Cited by 483
Kirschner, D. A., Inouye, H., Duffy, L. K., Sinclair, A., Lind, M., & Selkoe, D. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6953 · Cited by 482
The Stress Response and the Regulation of Inflammatory Disease
Sternberg, E. M., Chrousos, G. P., Wilder, R. L., & Gold, P. W. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-10-854 · Cited by 470
Anti-inflammatory drugs and Alzheimer disease
Mcgeer, P., Mcgeer, E., Rogers, J., & Sibley, J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91101-f · Cited by 437
Sapolsky, R. (1985) · The Journal of Neuroscience · doi:10.1523/jneurosci.05-05-01228.1985 · Cited by 400
The Amino Acid Sequence of a Major Nonimmunoglobulin Component of Some Amyloid Fibrils
Levin, M., Franklin, E. C., Frangione, B., & Pras, M. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107098 · Cited by 399
Arthritis and Allied Conditions
Currey, H. L. F. (1985) · Annals of the Rheumatic Diseases · doi:10.1136/ard.44.10.693-b · Cited by 376
Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord
Giulian, D., & Robertson, C. (1990) · Annals of Neurology · doi:10.1002/ana.410270107 · Cited by 372
D-Penicillamine Therapy in Progressive Systemic Sclerosis (Scleroderma): A Retrospective Analysis
STEEN, V. D., MEDSGER, T. A., & RODNAN, G. P. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-5-652 · Cited by 322
Cytokines as modulators of the hypothalamus-pituitary-adrenal axis
Besedovsky, H. O., Del Rey, A., Klusman, I., Furukawa, H., Monge Arditi, G., & Kabiersch, A. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90284-c · Cited by 314
Gold Salts in the Treatment of Rheumatoid Arthritis: A Double-Blind Study
SIGLER, J. W., BLUHM, G. B., DUNCAN, H., SHARP, J. T., ENSIGN, D. C., & MCCRUM, W. R. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-1-21 · Cited by 291
Haga, S., Akai, K., & Ishii, T. (1989) · Acta Neuropathologica · doi:10.1007/bf00687883 · Cited by 286
Haass, C., Hung, A., & Selkoe, D. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-12-03783.1991 · Cited by 282
Moshage, H. J., Roelofs, H. M. J., van Pelt, J. F., Hazenberg, B. P. C., van Leeuwen, M. A., Limburg, P. C., Aarden, L. A., & Yap, S. H. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81056-8 · Cited by 267
Vandenabeele, P., & Fiers, W. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90032-o · Cited by 264
IMMUNOLOGIC STUDIES OF THE MAJOR NONIMMUNOGLOBULIN PROTEIN OF AMYLOID
Levin, M., Pras, M., & Franklin, E. C. (1973) · The Journal of Experimental Medicine · doi:10.1084/jem.138.2.373 · Cited by 234
Felson, D. T., Anderson, J. J., & Meenan, R. F. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780351003 · Cited by 230
Adrenal glucocorticoids after twenty years
David, D. S., Grieco, M. H., & Cushman, P. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90078-0 · Cited by 209
Caporaso, G. L., Gandy, S. E., Buxbaum, J. D., & Greengard, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2252 · Cited by 203
Tooyama, I., Kimura, H., Akiyama, H., & McGeer, P. L. (1990) · Brain Research · doi:10.1016/0006-8993(90)91496-4 · Cited by 180
Matsuzawa, Y., & Hostetler, K. Y. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70769-8 · Cited by 167
α1‐Antichymotrypsin as a possible biochemical marker for Alzheimer‐type dementia
Matsubara, E., Hirai, S., Amari, M., Shoji, M., Yamaguchi, H., Okamoto, K., Ishiguro, K., Harigaya, Y., & Wakabayashi, K. (1990) · Annals of Neurology · doi:10.1002/ana.410280414 · Cited by 157
Immunosuppressive potential of antimalarials
Salmeron, G., & Lipsky, P. E. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91266-4 · Cited by 156
Abraham, C. R., Shirahama, T., & Potter, H. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90045-2 · Cited by 150
Glucocorticoids and hippocampal damage
Sapolsky, R. M. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90065-8 · Cited by 133
The disordered neuronal cytoskeleton in Alzheimer's disease
Lee, V. M. ‐., & Trojanowski, J. Q. (1992) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(92)90034-i · Cited by 129
Chloroquine Diphosphate in Rheumatoid Arthritis
Popert, A. J., Meijers, K. A. E., Sharp, J., & Bier, F. (1961) · Annals of the Rheumatic Diseases · doi:10.1136/ard.20.1.18 · Cited by 122
Cognitive dysfunction associated with naproxen and ibuprofen in the elderly
Goodwin, J. S., & Regan, M. G. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780250817 · Cited by 121
The participation of interleukin-6 in the pathogenesis of alzheimer's disease
Bauer, J., Ganter, U., Strauss, S., Stadtmüller, G., Frommberger, U., Bauer, H. C., Volk, B., & Berger, T. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80051-l · Cited by 110
Nordstedt, C., Gandy, S., Alafuzoff, I. I., Caporaso, G. L., Iverfeldt, K., Grebb, J. A., Winblad, B. G., & Greengard, P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.8910 · Cited by 109
Wallace, W., Bragin, V., Robakis, N. K. R. K., Sambamurti, K., VanderPutten, D. M., Merril, C. R., Davis, K. L., Santucci, A., & Haroutunian, V. H. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90108-a · Cited by 104
Gillis, S. A. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90098-r · Cited by 99
Rozemüller, A. J. M., Stam, F. C., & Eikelenboom, P. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90759-3 · Cited by 98
Central and Peripheral Endorphins: Basic and Clinical Aspects
Davis, G. C. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.5.664-a · Cited by 91
Complement activation and β-amyloid-mediated neurotoxicity in Alzheimer's disease
Rogers, J., Schultz, J., Brachova, L., Lue, L. F., Webster, S. M., Bradt, B. M., Cooper, N. R., & Moss, D. E. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80046-n · Cited by 90
Wallace, S. L. (1974) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(74)90006-7 · Cited by 81
Hydroxychloroquine sulfate (“Plaquenil”) in treatment of rheumatoid arthritis
Hamilton, E. B. D., & Scott, J. T. (1962) · Arthritis & Rheumatism · doi:10.1002/art.1780050507 · Cited by 80
Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid
Bannwarth, B., Netter, P., Pourel, J., Royer, R., & Gaucher, A. (1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90140-6 · Cited by 77
Pesanti, E. L., & Axline, S. G. (1975) · The Journal of Experimental Medicine · doi:10.1084/jem.141.5.1030 · Cited by 76
BERKENBOSCH, F., Refolo, L. M., Friedrich, V. L., Casper, D., Blum, M., & Robakis, N. K. R. K. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490250321 · Cited by 61
Effect of sulphasalazine on the radiological progression of rheumatoid arthritis.
Pullar, T., Hunter, J. A., & Capell, H. A. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.5.398 · Cited by 61
Bannwarth, B., Netter, P., Lapicque, F., Pr, P., Thomas, P., & Gaucher, A. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315572 · Cited by 56
Kitaguchi, N., Takahashi, Y., Oishi, K., Shiojiri, S., Tokushima, Y., Utsunomiya, T., & Ito, H. (1990) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(90)90017-a · Cited by 54
The predominant form of the amyloid beta-protein precursor in human brain is protease nexin 2.
Nostrand, W. E. V., Farrow, J. S., Wagner, S. L., Bhasin, R., Goldgaber, D., Cotman, C. W., & Cunningham, D. D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10302 · Cited by 53
Serum Amyloid P in Alzheimer's Disease
Kalaria, R. N., Golde, T. E., Cohen, M. L., & Younkin, S. G. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb00206.x · Cited by 52
Developmental expression of α1-antichymotrypsin in brain may be related to astrogliosis
Koo, E. H., Abraham, C. R., Potter, H., Cork, L. C., & Price, D. L. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90079-y · Cited by 49
Cytokines and inflammatory proteins in alzheimer's disease
BERKENBOSCH, F., Biewenga, J., Brouns, M. R., Rozemüller, A. J. M., Strijbos, P. J. L. M., & van Dam, A. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80052-m · Cited by 48
Kalaria, R. N., & Kroon, S. N. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80830-7 · Cited by 42
Eikelenboom, P., Hack, C. E., Kamphorst, W., & Rozemuller, J. M. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80044-l · Cited by 40
The role of the acute-phase protein α1-antichymotrypsin in brain dysfunction and injury
Abraham, C. R. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80047-o · Cited by 39
Kumar, A., Schapiro, M. B., Grady, C. L., Matocha, M. F., Haxby, J. V., Moore, A. M., Luxenberg, J. S., George‐Hyslop, P. S., Robinette, C. D., Ball, M. J., et al. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530140052017 · Cited by 37
Serological α1‐Antichymotrypsin in Down's syndrome and Alzheimer's disease
Brugge, K. L., Katzman, R., Hill, L. R., Hansen, L. A., & Saitoh, T. (1992) · Annals of Neurology · doi:10.1002/ana.410320211 · Cited by 35
Grinde, B., & Seglen, P. O. (1981) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1981.362.1.549 · Cited by 31
Complements, microglial cells and amyloid fibril formation
Ishii, T., & Haga, S. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80043-k · Cited by 25
Gorenstein, C. (1987) · Medical Hypotheses · doi:10.1016/0306-9877(87)90057-0 · Cited by 7
Cited by
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Parsons, C. G., Danysz, W., & Quack, G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00019-2 · Cited by 878
Cytokines and the Brain: Implications for Clinical Psychiatry
Kronfol, Z., & Remick, D. G. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.683 · Cited by 784
Barger, S. W., Hörster, D., Furukawa, K., Goodman, Y., Krieglstein, J., & Mattson, M. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9328 · Cited by 631
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1994-08-01
- Volume
- 151
- Issue
- 8
- Pages
- 1105-1113
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W38748857
- Cited by
- 326
- References
- 76
- FWCI
- 16.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.